Evigrade

Infectious conjunctivitis

Conjunctival inflammation of viral or bacterial origin. Viral cases account for 80 % in adults and self-resolve in 7–14 days. Bacterial cases receive a short course of topical antibiotics. Histamine is not a key mediator in pathogenesis; systemic antihistamines are not recommended in standard AAO guidelines.

ICD-10 H10.05 drugs

Also known as: Viral conjunctivitis, Bacterial conjunctivitis

Drugs used for this condition

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

How to read tiers A–F

Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.

  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit